Multicompartmentalized vesosomes containing DOX loaded liposomes and 5FU loaded liposomes for synergistic tumor treatment

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

DOI

  • Xunan Zhang, Harbin Institute of Technology
  • ,
  • Wei Zong, Harbin Institute of Technology
  • ,
  • Jialiang Wang, Jilin University
  • ,
  • Mingdong Dong
  • Wenlong Cheng, Monash University
  • ,
  • Tianmeng Sun, Jilin University
  • ,
  • Xiaojun Han, Harbin Institute of Technology

The first priority of drug combination therapy in the treatment of cancer is to achieve enhanced therapeutic efficacy and reduced side effects. The main issue in drug combination therapy is the inscrutable interaction between different drug components. Herein, we developed a multicompartmentalized architecture as a new delivery system. A host liposome encapsulates multiple guest liposomes, where various drug components were loaded into disparate compartments separately. This strategy avoids the interaction among different components before their arrival at the targeting sites and provides the fixed drug combination ratio as needed. Doxorubicin (DOX) and 5-fluorouacil (5FU) loaded smaller liposomes were encapsulated into bigger liposomes with a fixed dose ratio of DOX to 5FU. In vivo tumor growth inhibition by vesosomes was evaluated in HeLa tumor-bearing nude mice, which confirms the enhancement of the delivery system on the synergism of the drug combination.

Original languageEnglish
JournalNew Journal of Chemistry
Volume43
Issue12
Pages (from-to)4895-4899
Number of pages5
ISSN1144-0546
DOIs
Publication statusPublished - Mar 2019

    Research areas

  • COMBINATION, DELIVERY, DRUG-RELEASE, PH-SENSITIVE LIPOSOMES, VESICLES

See relations at Aarhus University Citationformats

ID: 150348466